POZ - Latino Hub : Treatment News

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
|
|
|
|
|
|
|
|
|

Back to home » News & Views » Treatment News


 
October 30, 2008
Long-Term Benefits and Risks of Kaletra Monotherapy Explored in Two Studies
October 29, 2008
OraSure Seeking FDA Approval for Rapid Hep C Test
EMD Serono Buys Rights to Sell Tesamorelin in U.S.
Has HIV Evolved to Become More Dangerous?
October 28, 2008
PRO 140 Has Long-Lasting Activity Against HIV
Greater HIV Response to Prezista vs. Kaletra for First-Timers Over 96 Weeks
New NNRTI Called RDEA806 Shows Promise
Higher Response Rate with Norvir-Boosted Reyataz vs. Kaletra as First-Line Therapy
October 27, 2008
Isentress Comparable to Sustiva for First-Time Treatment
Selzentry Reanalysis Shows Potential as First-Line Treatment
Should ARV Treatment Be Started When CD4s Fall Below 500?
October 24, 2008
Blood Clots More Common in People With Advanced HIV Disease
October 23, 2008
'Undetectable = Noninfectious' Debate Continues at U.K. Conference
October 22, 2008
Prezista Approved for First-Time Treatment Takers
October 21, 2008
SMART Study: Viral Loads and Inflammation Explain Increased Cardio Risk
October 20, 2008
Norvir and Viral Hepatitis Increase HIV Drug levels, Risk of Side Effects
October 17, 2008
50% of MRSA Skin Infections Return Within 1 Year
October 16, 2008
Treatment Interruption After an Early Start Produced Steep CD4 Declines
October 15, 2008
Third Dose of Hep A Vaccine May Increase Immunity
October 14, 2008
Menopause, Tenofovir and Didanosine Increase Bone Loss
October 13, 2008
New Anti-HIV Drug Target Discovered
October 10, 2008
Single Dose of Diflucan Good for Thrush
October 09, 2008
Strength Training Burns More Fat Than Endurance Exercise in HIV
October 08, 2008
Merck Testing Once-Daily Isentress
October 07, 2008
Low CD4s in People With Hepatitis and HIV Associated with Liver Cancer
October 06, 2008
Pneumonia Hospitalizations Still High for Positive Patients
October 03, 2008
Tenofovir Linked to Mild Decrease in Kidney Function, but Not Kidney Disease
October 02, 2008
FDA Approves Boosted-Reyataz for Treatment First-Timers
October 01, 2008
Delayed-Release Videx (EC) Now OK for Some Kids

 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
 
Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.